MIAMI, Aug. 24, 2009 (GLOBE NEWSWIRE) -- The securities law firm of Dimond Kaplan & Rothstein, P.A. (http://www.dkrpa.com or http://www.investmentfraud-lawyer.com) issued a press release on August 24, 2009 concerning FINRA securities arbitration claims that it expects to file against brokerage firms that sold Medical Capital investments. In its press release, the law firm incorrectly identified GunnAllen one of the brokerage firms that sold Medical Capital investments. It is Dimond Kaplan & Rothstein's understanding that GunnAllen did not sell Medical Capital investments. The firm apologizes for any confusion this may have caused.
Investors who bought Medical Capital notes from a brokerage firm, including Securities America, CapWest Financial, Okoboji, QA 3 Financial, and Capital Financial Services, may be able to recover their investment losses through FINRA arbitration claims.
Dimond Kaplan & Rothstein, P.A. is an AV-Rated law firm that represents investors nationwide in stockbroker fraud and investment loss cases. The firm has represented investors against most major Wall Street brokerage firms in claims involving limited partnerships, stocks, bonds, options, and hedge funds. If you suffered investment losses in Medical Capital investments, please contact Jeffrey Kaplan, Esq. of Dimond Kaplan & Rothstein, P.A. at (888) 578-6255 or jkaplan@dkrpa.com for a free case evaluation. You also may visit the firm on the web at www.dkrpa.com or www.investmentfraud-lawyer.com.